Roberto Ruggiero

Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice

P. Calabrò, F. Gragnano, F. C. Sasso, 2023, International journal of molecular sciences.